Analyst Ratings for Atea Pharmaceuticals (AVIR)

AVIR Rating Summary

AVIR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AVIR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $63.50 (+171%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/25/2020 Evercore ISI Umer Raffat New Coverage Outperform
(N/A)
N/A
(N/A)
34.07
(23.43)
-31.23% Details
11/24/2020 Morgan Stanley
» Updated 4/6/2021
Matthew Harrison New Coverage Overweight
(N/A)
82.00
(49.00)
33.54
(23.43)
-30.14% Details
Like AVIR Ratings? Also take a look at RHHBY, ROG, ADAP

AVIR Ratings News